Chondrial Therapeutics

Chondrial Therapeutics LLC was established to discover and develop orphan drugs for mitochondrial diseases. Their proprietary protein replacement platform initially targets Friedreich's ataxia, a condition that afflicts more than 20,000 people in the United States and Europe. Their goal is to restore normal life for patients with mitochondrial diseases. Hope is on the horizon.